Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Fig. 2

Mitochondrial dysfunction and its association with neurodegenerative disorders. Several mitochondria abnormalities are characterized by a loss of efficiency in the electron transport chain (ETC) and dysfunction in ATP-synthesis machinery. Reactive oxygen species (ROS) is a consequence of the electron transport process, produced as a by-product of oxidative phosphorylation. Furthermore, structural anomalies might lead to an increased ROS production and the release of mitochondria-derived proapoptotic factors. These free radicals can damage cellular lipids, proteins, and DNA, including mtDNA, which entails dysfunctional mitochondria associated with aging, and essentially, all chronic diseases include neurodegenerative pathologies

Back to article page